Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tsubakihara

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Clinical Immunology (Orlando, Fla.)|April 26, 2000
Urine levels of CD46 (membrane cofactor protein) are increased in patients with glomerular diseasesT Shoji, I Nakanishi, K Kunitou, et al.
Nephron|November 27, 2001
Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapyE Muso, M Mune, Y Fujii, et al.
Kidney International. Supplement|July 21, 1999
Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study GroupE Muso, M Mune, Y Fujii, et al.
Clinical Therapeutics|May 1, 1997
Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study GroupT Itoh, M Matsumoto, H Hougaku, et al.
Clinical Nephrology|September 2, 1998
Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysisK Yoshimoto, S Saima, Y Nakamura, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Clinical Immunology (Orlando, Fla.)|April 26, 2000
Urine levels of CD46 (membrane cofactor protein) are increased in patients with glomerular diseasesT Shoji, I Nakanishi, K Kunitou, et al.
Nephron|November 27, 2001
Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis compared with steroid monotherapyE Muso, M Mune, Y Fujii, et al.
Kidney International. Supplement|July 21, 1999
Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study GroupE Muso, M Mune, Y Fujii, et al.
Clinical Therapeutics|May 1, 1997
Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study GroupT Itoh, M Matsumoto, H Hougaku, et al.
Clinical Nephrology|September 2, 1998
Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysisK Yoshimoto, S Saima, Y Nakamura, et al.
Pageof 4